NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/27/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization58.71 mln
Float5.28 mln
Earnings Date09/10/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-6.18
Highly reliable
Relative Strength
96
/ 100
Top performer
Debt / Equity
0.04
Debt-free
ROE
-120
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Nutriband Inc. is a Florida-based company focused on developing skin patch medications designed to reduce the risk of drug misuse and abuse. Its main product, AVERSA fentanyl, is a patch that delivers pain relief steadily over time while making it harder to misuse, targeting patients who need continuous opioid treatment for chronic pain. The company is also working on similar patch-based versions of buprenorphine and methylphenidate, and partners with Kindeva Drug Delivery to support its development and supply needs.
